Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Ranieri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annali Italiani Di Chirurgia|January 21, 2015
Clinical comparison between wall defects surgery using conventional and low-adhesion mesh materials Preliminary resultsMarco Basile, Elisabetta Ranieri, Maria Di Nicola, et al.
Revue Medicale Suisse|October 17, 2025
[Updates in Postpartum haemorrhage management]Mélanie Suppan, Elisabetta Ranieri, Christian Haslinger, et al.
BMJ Open|May 9, 2025
Effects of early factor XIII replacement in postpartum hae morrhage: study protocol for a multicentre, open-label, randomised, controlled, investigator-initiated trialChristian Haslinger, Torsten Hothorn, Verena Bossung, et al.
British Journal of Haematology|January 3, 2024
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumabRoman R Schimmer, Tabea Sutter, Adrian Bachofner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annali Italiani Di Chirurgia|January 21, 2015
Clinical comparison between wall defects surgery using conventional and low-adhesion mesh materials Preliminary resultsMarco Basile, Elisabetta Ranieri, Maria Di Nicola, et al.
Revue Medicale Suisse|October 17, 2025
[Updates in Postpartum haemorrhage management]Mélanie Suppan, Elisabetta Ranieri, Christian Haslinger, et al.
BMJ Open|May 9, 2025
Effects of early factor XIII replacement in postpartum hae morrhage: study protocol for a multicentre, open-label, randomised, controlled, investigator-initiated trialChristian Haslinger, Torsten Hothorn, Verena Bossung, et al.
British Journal of Haematology|January 3, 2024
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumabRoman R Schimmer, Tabea Sutter, Adrian Bachofner, et al.
Pageof 1